SmartLab 2.0 en prevención cardiovascular de dislipemia aterogénica-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SmartLab 2.0 en prevención cardiovascular de dislipemia aterogénica

Published:2022-11 Issue: Volume: Page:
ISSN:0214-9168
Container-title:Clínica e Investigación en Arteriosclerosis
language:es
Short-container-title:Clínica e Investigación en Arteriosclerosis

Author:

Galván Toribio Raquel,Arrobas Velilla Teresa,Morales Porillo Cristóbal,Rico Miguel Ángel,Martínez Quesada Mar,León Justel Antonio

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine

Reference15 articles.

1. European Society of Cardiology: Cardiovascular disease statistics 2021;Timmis;Eur Heart J.,2022

2. Epidemiology of cardiovascular disease in Europe;Townsend;Nat Rev Cardiol.,2022

3. Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials;Biagen;Lancet.,2010

4. Management of dyslipidemia in the metabolic syndrome: Recommendations of the Spanish HDL-Forum;Ascaso;Am J Cardiovasc Drugs.,2007

5. ApolipoproteinB and cardiovascular disease risk: Position statement from the AACC Lipoproteins and Vascular Disease Working Group on Best Practices;Contois;Clin Chem,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP